Table 1 Demographics and clinical characteristics of CoronaVac-vaccinated individuals and COVID-19 patients.
Characteristics | Vaccinated individualsa (N = 111) | COVID-19 patientsb (N = 111) |
|---|---|---|
Demographics | ||
Age (years), median (IQR) | 35 (28–47) | 53 (41–63) |
Male, n (%) | 35 (31.5%) | 45 (40.5) |
Female, n (%) | 76 (68.5%) | 66 (59.5) |
Vaccination history, n (%) | ||
Unvaccinated | 0 | 17 (15.3) |
Homologous inactivated vaccine (1–2 doses) | 111 (100) | 10 (10.6) |
Homologous viral vector vaccine (1–2 doses) | 0 | 31 (33.0) |
Homologous mRNA vaccine (2–3 doses) | 0 | 4 (4.3) |
Heterologous vaccine (2–5 doses)*** | 0 | 49 (52.1) |
Pre-existing conditions, n (%) | ||
No underlying disease | 79 (63.3%) | 47 (42.3) |
Hypertension | 6 (5.4%) | 35 (31.5) |
Dyslipidemia | 8 (7.2%) | 30 (27.0) |
Diabetes mellitus | 5 (4.5%) | 18 (16.2) |
Chronic heart disease | 0 | 8 (7.2) |
Obesity (BMI > 30) | 12 (10.8%) | 20 (18.0) |
Asthma | 3 (2.7%) | 4 (3.6) |
Cancer | 0 | 1 (0.9) |
Rheumatologic disease | 0 | 5 (4.5) |
Day to enrollment, median (IQR) | ND | 1 (0–2) |
Pneumonia | ND | 41 (36.9) |
Organ involved and complications, n (%) | ||
Lung | ND | 64 (57.7) |
Liver | ND | 13 (11.7) |
Kidney | ND | 5 (4.5) |
In-hospital death, n (%) | ND | 0 |
